{"id":51151,"date":"2022-11-22T19:02:12","date_gmt":"2022-11-22T18:02:12","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\/"},"modified":"2022-11-22T19:02:12","modified_gmt":"2022-11-22T18:02:12","slug":"recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\/","title":{"rendered":"ReCode Therapeutics to Present at Upcoming Investor Conferences in 2022"},"content":{"rendered":"
\n

MENLO PARK, Calif. & DALLAS–(BUSINESS WIRE)–ReCode Therapeutics<\/a>, a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, announced today that Company leadership will participate in two upcoming investor conferences:\n<\/p>\n

<\/a><\/p>\n

\nPiper Sandler 34th Annual Healthcare Conference
\n
<\/b>Format:<\/b> Company Presentation
\n
Date: <\/b>Tuesday, November 29, 2022
\n
Time:<\/b> 11:30 a.m. ET
\n
Location:<\/b> New York, NY\n<\/p>\n

\n2022 RBC Capital Markets Healthcare Private Company Conference
\n
<\/b>Format: <\/b>Fireside Chat
\n
Date: <\/b>Thursday, December 15, 2022
\n
Time:<\/b> 9:20 a.m. ET
\n
Location:<\/b> Virtual\n<\/p>\n

\nAbout ReCode Therapeutics<\/b>\n<\/p>\n

\nReCode Therapeutics is a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode\u2019s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation, genetic medicines technology that enables precise delivery to target organs and cells beyond the liver. The SORT LNP platform is the foundation for ReCode\u2019s pipeline of disease-modifying mRNA and gene correction therapeutics. ReCode\u2019s lead programs are focused on primary ciliary dyskinesia and cystic fibrosis. ReCode is leveraging its SORT LNP platform and nucleic acid technologies to expand its pipeline with therapeutics that use mRNA-mediated replacement and gene correction in target organs with precision targeting of disease-relevant cells. For more information, visit www.recodetx.com<\/a> and follow us on Twitter @ReCodeTx<\/a> and on LinkedIn<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Contact:<\/span><\/b>
Sarah McCabe
\n
Stern IR
\n
sarah.mccabe@sternir.com<\/a>
IR@recodetx.com<\/a>\n<\/p>\n

\nMedia Contact:<\/span><\/b>
Tara Cooper
\n
The Grace Communication Group
\n
tara@gracegroup.us<\/a>
650-303-7306\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

MENLO PARK, Calif. & DALLAS–(BUSINESS WIRE)–ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, announced today that Company leadership will participate in two upcoming investor conferences: Piper Sandler 34th Annual Healthcare Conference Format: Company Presentation Date: Tuesday, November 29, 2022 Time: 11:30 a.m. ET … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51151","6":"format-standard","7":"category-industry"},"yoast_head":"\nReCode Therapeutics to Present at Upcoming Investor Conferences in 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ReCode Therapeutics to Present at Upcoming Investor Conferences in 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MENLO PARK, Calif. & DALLAS–(BUSINESS WIRE)–ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, announced today that Company leadership will participate in two upcoming investor conferences: Piper Sandler 34th Annual Healthcare Conference Format: Company Presentation Date: Tuesday, November 29, 2022 Time: 11:30 a.m. ET ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-22T18:02:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221122005008\/en\/1498350\/21\/ReCode_Logo_Primary_Web%402000px.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"ReCode Therapeutics to Present at Upcoming Investor Conferences in 2022\",\"datePublished\":\"2022-11-22T18:02:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\\\/\"},\"wordCount\":246,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221122005008\\\/en\\\/1498350\\\/21\\\/ReCode_Logo_Primary_Web%402000px.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\\\/\",\"name\":\"ReCode Therapeutics to Present at Upcoming Investor Conferences in 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221122005008\\\/en\\\/1498350\\\/21\\\/ReCode_Logo_Primary_Web%402000px.jpg\",\"datePublished\":\"2022-11-22T18:02:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221122005008\\\/en\\\/1498350\\\/21\\\/ReCode_Logo_Primary_Web%402000px.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221122005008\\\/en\\\/1498350\\\/21\\\/ReCode_Logo_Primary_Web%402000px.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ReCode Therapeutics to Present at Upcoming Investor Conferences in 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ReCode Therapeutics to Present at Upcoming Investor Conferences in 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\/","og_locale":"en_US","og_type":"article","og_title":"ReCode Therapeutics to Present at Upcoming Investor Conferences in 2022 - Pharma Trend","og_description":"MENLO PARK, Calif. & DALLAS–(BUSINESS WIRE)–ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, announced today that Company leadership will participate in two upcoming investor conferences: Piper Sandler 34th Annual Healthcare Conference Format: Company Presentation Date: Tuesday, November 29, 2022 Time: 11:30 a.m. ET ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-22T18:02:12+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221122005008\/en\/1498350\/21\/ReCode_Logo_Primary_Web%402000px.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"ReCode Therapeutics to Present at Upcoming Investor Conferences in 2022","datePublished":"2022-11-22T18:02:12+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\/"},"wordCount":246,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221122005008\/en\/1498350\/21\/ReCode_Logo_Primary_Web%402000px.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\/","url":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\/","name":"ReCode Therapeutics to Present at Upcoming Investor Conferences in 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221122005008\/en\/1498350\/21\/ReCode_Logo_Primary_Web%402000px.jpg","datePublished":"2022-11-22T18:02:12+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221122005008\/en\/1498350\/21\/ReCode_Logo_Primary_Web%402000px.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221122005008\/en\/1498350\/21\/ReCode_Logo_Primary_Web%402000px.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"ReCode Therapeutics to Present at Upcoming Investor Conferences in 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51151","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51151"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51151\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51151"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51151"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51151"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}